Another limitation presents as an ineffectiveness in terms of screening for subclinical HF due to the low sensitivity of NT-proBNP, which tends to increase in plenty of conditions such as arrhythmias, valvular heart disease, pulmonary hypertension, pulmonary thromboembolism, sepsis, and many others [11]. The gene discussed is NPPB; the disease is hydrops fetalis.